Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

FDA On Legal Tightrope In Push To Restrict Drug Ads No Photo Available

Dan McKay

The U.S. Food and Drug Administration helped unleash a flood of "direct to consumer" drug advertisements in the 1990s. Copious First A... (more story)

Oregon Joins Expansion Of '5NP' Acupuncture Practice No Photo Available

Gianna Ferrarin

Oregon has joined a number of states that have enacted laws that make it easier for people to get a "five needle" therapy with a raft ... (more story)

The Limits On Blue States' Push For Vaccine Policy Control No Photo Available

Yeji Jesse Lee

Democratic-run states are changing vaccine policies as HHS Secretary Robert F. Kennedy Jr. and other Trump health officials move to re... (more story)